DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Luangchosiri C, Thakkinstian A, Chitphuk S. et al.
A double-blinded randomized controlled trial of silymarin for the prevention of
antituberculosis drug-induced liver injury.
BMC Complement Altern Med 2015;
15: 1-7
DOI: 10.1186/s12906-015-0861-7.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.